Argos Therapeutics Announces Globalization of Pivotal Phase 3 ADAPT Study for Personalized Cancer Immunotherapy
September 24, 2013 08:07 ET
|
Argos Therapeutics
DURHAM, N.C., Sept. 24, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the...
JAIDS Study by Argos Therapeutics Evaluates Impact of Personalized Immunotherapy in HIV-Infected Patients
September 16, 2013 08:07 ET
|
Argos Therapeutics
DURHAM, N.C., Sept. 16, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the...
Argos Therapeutics to Present at the Stifel Healthcare Conference 2013
September 06, 2013 09:45 ET
|
Argos Therapeutics
DURHAM, N.C., Sept. 6, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the...
Argos Therapeutics Secures $42.5 Million Financing, Funds Pivotal Phase 3 ADAPT Trial for Personalized Immunotherapy
August 27, 2013 08:00 ET
|
Argos Therapeutics
DURHAM, N.C., Aug. 27, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the...
Inc. Unveils Its Annual Exclusive List of America's Fastest-Growing Private Companies
August 20, 2013 13:08 ET
|
Inc.
New York, Aug. 20, 2013 (GLOBE NEWSWIRE) -- Inc., the only major business media brand aimed solely
at business owners, has unveiled its annual exclusive lists of the
fastest-growing private companies...
Argos Therapeutics Identifies Topical Formulation for Prolonged Graft Survival in Corneal Transplants
August 15, 2013 08:03 ET
|
Argos Therapeutics
DURHAM, N.C., Aug. 15, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of therapies that modulate the immune system to...
Inc. Magazine announces 2nd annual Hire Power Awards Program
July 11, 2013 10:26 ET
|
Inc.
New York, July 11, 2013 (GLOBE NEWSWIRE) --
Inc. Magazine and Bank of America
Merrill Lynch are proud to recognize American companies that have
greatly increased their workforces. ...
The Creators of the Inc. 5000 Introduce a New Business Index Recognizing America's Enduring Job Creators -- The Build 100
July 02, 2013 11:01 ET
|
Inc.
New York, July 2, 2013 (GLOBE NEWSWIRE) -- What is the only statistically significant predictor of a
company's future success? It's not location, industry, or huge
bursts of growth. Rigorous economic...
Argos Therapeutics Announces Plans for HIV Eradication Study
July 01, 2013 15:03 ET
|
Argos Therapeutics
DURHAM, N.C., July 1, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the...
Leading HIV Researchers and Argos Therapeutics Highlight Importance of Immunotherapy in HIV Eradication Efforts
June 13, 2013 09:59 ET
|
Argos Therapeutics
DURHAM, N.C., June 13, 2013 (GLOBE NEWSWIRE) -- In conjunction with the U.S. Food and Drug Administration's (FDA) June 14th Public Meeting on HIV Patient-Focused Drug Development and HIV Cure...